Pharmaceutical companies reach Alzheimer's treatment breakthrough with new drug
Two pharmaceutical companies may have a potential breakthrough treatment for Alzheimer's with a new drug.
•
Sep 29, 2022, 3:53 PM
•
Updated 709 days ago
Share:
Two pharmaceutical companies may have a potential breakthrough treatment for Alzheimer's with a new drug.
The drug is called Lecanemab.
An 18-month trial, showed it slowed the progress of the disease by 27%, compared to those who received a placebo.
The companies will apply for regulatory approval of the drug in the U.S. by the end of the year.
More from News 12
2:09
Emergency sewer repair project in Greenburgh stinks – but it’s necessary, officials say
1:57
Chilly morning, pleasant afternoon Sunday in the Hudson Valley
1:58
Residents learn more about $12.9M facelift proposal for Nanuet Public Library
0:48
Rain doesn't damper celebration at 13th annual Italian Feast and Festival in Tappan
0:53
Nearly $2 million to fund intelligence center, body cameras for Orange County law enforcement
2:00
